Prevention of Post-ERCP Pancreatitis by Indomethacin vs Diclofenac

NCT05947461 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
1204
Enrollment
OTHER
Sponsor class

Stopped The data from the interim analysis showed a opposite trend predicting possible of benefit of indomethacin and conditional power analysis revealed a low probability of confirming the benefit of diclofenac if this trial will be continued.

Conditions

Interventions

Sponsor

Air Force Military Medical University, China